50 results on '"Macher, Stefan"'
Search Results
2. Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study
3. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension – an assessment of sick leave, presenteeism, and health care utilization
4. The additive value of complementing diagnostic idiopathic intracranial hypertension criteria by MRI – an external validation study
5. Gravity-Dependent Modulation of Downbeat Nystagmus and Subjective Visual Vertical in the Roll Plane
6. The Vienna idiopathic intracranial hypertension database—An Austrian registry
7. Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease
8. Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
9. Retinal Layer Thinning for Monitoring Disease-modifying Treatment in Relapsing Multiple Sclerosis—Evidence for Applying a Rebaselining Concept (P6-6.005)
10. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension – a comprehensive assessment of patient satisfaction
11. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension – an assessment of sick leave, presenteeism, and health care utilization
12. An interdisciplinary integrated specialized one‐stop outpatient clinic for idiopathic intracranial hypertension—a comprehensive assessment of clinical outcome.
13. Plasma Calcitonin Gene-Related Peptide Levels in Idiopathic Intracranial Hypertension: An Exploratory Study
14. HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease.
15. The Vienna idiopathic intracranial hypertension database—An Austrian registry
16. Clinical scales in autoimmune encephalitis—A retrospective monocentric cohort study
17. MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome
18. Impact of rater experience and referral question on detecting MRI features of idiopathic intracranial hypertension
19. Reported neurological symptoms after severe acute respiratory syndrome coronavirus type 2 infection: A systematic diagnostic approach
20. Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
21. Addition of optic nerve involvement to dissemination in space criteria for multiple sclerosis – the value of optical coherence tomography (S46.009)
22. Impact of rater experience and referral question on detecting magnetic resonance imaging features of idiopathic intracranial hypertension.
23. Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes
24. Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis
25. Impact of rater experience on detecting MRI features of idiopathic intracranial hypertension
26. Additional file 1 of Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
27. Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis.
28. Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcome
29. Has the pandemic changed treatment strategy in multiple sclerosis?
30. Visuo-constructional functions in patients with mild cognitive impairment, Alzheimer’s disease, and Parkinson’s disease
31. The Vienna Idiopathic Intracranial Hypertension (VIIH) database – an Austrian registry
32. Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic Encephalitis
33. Denervation Dynamics After Intramuscular BNT Injection in Patients With Focal Spasticity Monitored by MRI and Dynamometry–a Blinded Randomized Controlled Pilot Study
34. Neuropathological Variability within a Spectrum of NMDAR ‐Encephalitis
35. Magnetic Resonance Imaging Signs of Idiopathic Intracranial Hypertension.
36. Ocular Motor Abnormalities in Anti-IgLON5 Disease
37. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
38. Functional Recovery in Autoimmune Encephalitis: A Prospective Observational Study
39. Autoimmune Global Amnesia as Manifestation of AMPAR Encephalitis and Neuropathologic Findings
40. Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis
41. Longitudinal CSF Findings in Autoimmune Encephalitis—A Monocentric Cohort Study
42. Longitudinal measurement of cerebrospinal fluid neurofilament light in anti‐N‐methyl‐D‐aspartate receptor encephalitis
43. Longitudinal measurement of cerebrospinal fluid neurofilament light in anti‐N‐methyl‐D‐aspartate receptor encephalitis.
44. Management of Autoimmune Encephalitis: An Observational Monocentric Study of 38 Patients
45. Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis
46. Clinical manifestations of the anti-IgLON5 disease
47. Patient satisfaction with flexible botulinum toxin injection intervals: Preliminary results of a telephone survey
48. Backtesting und Stresstesting von Marktrisikomodellen
49. Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis—Evidence for applying a rebaselining concept.
50. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.